* Precision BioSciences Inc DTIL.OQ reported quarterly
adjusted
earnings of $4.67 per share for the quarter ended in June,
higher than the same quarter last year, when the company
reported EPS of $-3.00. The mean expectation of seven analysts
for the quarter was for a loss of $1.50 per share. Wall Street
expected results to range from $-2.87 to -50 cents per share.
* Revenue rose 152.2% to $49.90 million from a year ago;
analysts
expected $8.86 million.
* Precision BioSciences Inc's reported EPS for the quarter
was
$4.67.
* The company reported quarterly net income of $32.75
million.
* Precision BioSciences Inc shares had fallen by 1.6% this
quarter and lost 12.6% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 17.5%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"
Wall Street's median 12-month price target for Precision
BioSciences Inc is $30.00
This summary was machine generated from LSEG data August 2 at
07:48 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 -1.50 -0.35 Beat
Mar. 31 2024 -1.91 -0.35 Beat
Dec. 31 2023 -2.05 -4.06 Missed
Sep. 30 2023 -4.87 -2.10 Beat